ISPOR HEALTH TECHNOLOGY ASSESSMENT SPECIAL INTEREST GROUP (HTA)

Global Health Care Reimbursement Systems and Decision Processes Working Group


Co-chairs:
Stefan Holmstrom BSc, MSc, Director HEOR, Astellas Pharma Europe, Leiderdorp, The Netherlands
Karl Matuszewski MS, PharmD, Vice President, Editor-in-Chief Elsevier / Gold Standard, Tampa, FL, USA
Kevin Mayo PhD, Senior Director of Health Outcomes and PharmacoEconomics (HOPE), Endo Pharmaceuticals Inc, Chadds Ford, Pennsylvania, USA Adjunct professor, University of the Sciences in Philadelphia, Pennsylvania, USA
Noreen Sullivan BS, Vice President, U.S. Business Development, Resonance Health Limited, Encinitas, CA, USA
Sheryl Szeinbach BS, MS, PhD, RPh, Professor, College of Pharmacy, Ohio State University, Columbus, OH USA

Leadership Group
Amit Chhabra MD, MPH, Outcomes Research Reimbursment Manager, Medtronic, Europe Sarl, Tolochenaz, Switzerland
Annie Chicoye, Senior Principal Director Pricing & Market Access IMS Consulting, Puteaux cedex, France
Eric Faulkner, Senior Director RTI Health Solutions, Director, Genomics Biotech Institute, Research Triangle Park, NC, USA
Anke-Peggy Holtorf PhD, MBA, Business Director, BioBridge Strategies, Basel, Switzerland
Hans Middelhoven PhD, F. Hoffmann – La Roche Ltd., Basel, Switzerland
Mark Nuijten PhD, MD, MBA Erasmus University, Rotterdam, The Netherlands
W. Neil Palmer, Vice-President, Pricing and Reimbursement, RTI Health Solutions, Ottawa, Canada
Mayvis Rebeira MBA, MA, Economist, Ministry of Health, Toronto, ON, Canada
Jose-Manuel Rodriguez Barrios PharmD, MPH, MSc, Health Economics Reimbursement Manager, Medtronic, Iberia, Madrid, Spain
Enrique Seoane-Vazquez PhD, Assistant Professor Ohio State University, Columbus, OH, USA
Carolyn Steeds BSc, Independent Consultant, Carolyn Steeds Consulting, Motherwell, Scotland
Christoph Vauth PhD, Head of Integrated Health care (IGV), KKH-Allianz , Hanover, Germany
Konrad RB Wallerstein, Adelphi Focus, Doylestown, PA, USA
Feng Zeng PhD, Health Economist, MedImpact Healthcare Systems, San Diego, CA

Objectives:
  1. To develop a country-specific roadmap of pharmaceuticals reimbursement systems in health care
  2. To describe decision-makers and the decision making processes for coverage and payment of new and emerging pharmaceuticals
  3. To provide public access to the information at the ISPOR website
Accomplishments / Activities:
Country Contributors
Asia - Comparative table of health care systems
ISPOR Asia Consortium
Australia
Sheryl Szeinbach BS, MS, PhD, RPh, Professor, College of Pharmacy, Ohio State University, Columbus, OH USA
Enrique Seoane-Vazquez PhD, Assistant Professor Ohio State University, Columbus, OH, USA
Austria
Patricia Buchholz, RPh, PhD, PBC Patricia Buchholz Consulting, Germany
Canada
W. Neil Palmer, Vice-President, Pricing and Reimbursement, RTI Health Solutions, Ottawa, Canada
China
Feng Zeng PhD, Health Economist, MedImpact Healthcare Systems, San Diego, CA
Denmark
Martin Strandberg-Larsen MSc, PhD, Health Economist, Global Development, Novo Nordisk A/S, Soeborg, External Lecturer, University of Copenhagen, Denmark
Martin S. Knudsen MSc, Senior Consultant, Health Economics and Outcomes Research, IMS Health, Holborn, United Kingdom
Randa Eldessouki MD, DrPH, Director, ISPOR scientific initiatives, ISPOR, NJ, USA

France
Amit Chhabra MD, MPH, Outcomes Research Reimbursment Manager, Medtronic, Europe Sarl, Tolochenaz, Switzerland
Annie Chicoye, Senior Principal Director Pricing & Market Access IMS Consulting, Puteaux cedex, France
Stefan Holmstrom, MSc., Dir HEOR, Astellas Pharma Europe, Leiderdrop, The Netherlands
Nazanin Mehin, Ass Dir Health Economics and Reimbursement Argumentation, Sanofi Aventis, Paris, France

Germany
Anke-Peggy Holtorf, PhD, MBA, Business Director, BioBridge Strategies, Basel, Switzerland
Karl Matuszewski MS, PharmD, Senior Director, Clinical Knowledge Service, University HealthSystem Consortium, Oak Brook, IL, USA
Mark Nuijten PhD, MD, MBA Erasmus University, Rotterdam, The Netherlands
Christoph Vauth PhD, Head of Integrated Health care (IGV), KKH-Allianz , Hanover, Germany
Noreen Sullivan BS, President and CEO Technology Assessment Evaluation Group LLC, Encinitas, CA, USA
Greece
Angeliki Angeli MSc, Institutional Relations and Communication Director, Sanofi Aventis, Athens, Greece
Hungary
Gulacsi Laszlo PhD, Health Economics and Technology Assessment Research Centre, Corvinus University of Budapest, Budapest, Hungary
Ireland
John Joseph Coughlan, Duncan Fortescue-Webb, Roisin Heaney, Gillian Judge, Dr. Lesley Tilson, Dr. Michael Barry, Members of NCPE
Randa Eldessouki MD, DrPH, Director, ISPOR scientific initiatives, ISPOR, NJ, USA

Italy
Hans Middelhoven PhD, F. Hoffmann – La Roche Ltd., Basel, Switzerland
Latin America - Comparative table of healthcare systems
ISPOR Latin America Consortium
The Netherlands
Mark Nuijten PhD, MD, MBA Eramus University, Rotterdam, The Netherlands
Poland
Marcin Czech PhD, MD, MBA, Past President, ISPOR Poland Regional Chapter & Adjunct, Dept of Pharmacoeconomics, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland
Scotland
Carolyn Steeds BSc, Independent Consultant, Carolyn Steeds Consulting, Motherwell, Scotland

Spain
Jose-Manuel Rodriguez Barrios PharmD, MPH, MSc, Health Economics Reimbursement Manager, Medtronic, Iberia, Madrid, Spain
Hans Middlehoven PhD , F. Hoffmann – La Roche Ltd., Basel, Switzerland
Enrique Seoane-Vazquez PhD, Assistant Professor Ohio State University, Columbus, OH, USA
Sheryl Szeinbach BS, MS, PhD, RPh, Professor, College of Pharmacy, Ohio State University, Columbus, OH USA

Sweden
Eric Faulkner, Senior Director RTI Health Solutions, Director, Genomics Biotech Institute, Research Triangle Park, NC, USA
Karl Matuszewski MS, PharmD, Senior Director, Clinical Knowledge Service, University HealthSystem Consortium, Oak Brook, IL, USA
Christie Niziol, Associate Director- Global Services, ,Abacus International, UK
Taiwan
Tony, Yen-Huei Tarn MS, PhD (譚延輝), Director, Division of Health Technology Assessment Center for Drug Evaluation Taipei, Taiwan
UK
Rebecca Townsend BSc, Project Director, Evidence Research Unit, Macclesfield, UK
USA
Karl Matuszewski MS, PharmD, Senior Director, Clinical Knowledge Service, University HealthSystem Consortium, Oak Brook, IL, USA
Noreen Sullivan BS, President and CEO Technology Assessment Evaluation Group LLC, Encinitas, CA, USA

 

Global HTA used in Health Care Reimbursement WG Members Access Only

  How to login

User name: first part of the email address (before @)
e.g. for jdoe@ispor.org it should be jdoe)
Password: ISPOR Member ID.

  Click here for login help

 


HTA SIG | Special Interest Groups Index
 

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2010 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.
 
Website design by Eagle Systems USA, Inc.